EU Authorisation for FUMzyme Proves Fumonisin Biotransformation03 November 2014
EU - Biomin has announced the EU authorisation of FUMzyme® as 'substances for reduction of the contamination of feed by mycotoxins'.
FUMzyme, part of the well-established Mycofix® product line of Biomin, is the first-ever purified enzyme authorized by the EU, proven to biotransform fumonisins into non-toxic metabolites.
The product has proven to be effective in degrading fumonisins to compounds of significantly lower toxicity in the gastrointestinal tract of animals. The sphinganine/sphingosine ratio, considered the most sensitive endpoint for fumonisin toxicosis, was included as an important parameter in several short- and long-term feeding studies conducted with pigs.
Until now, the binding of fumonisins to adsorptive substances was the only solution available to counter fumonisin intoxication. Due to the molecular structure of these mycotoxins and pH dependence of the reaction, fumonisins are only insufficiently adsorbed by mycotoxin-binding products in the gastrointestinal tract.
According to current Biomin Mycotoxin Survey results of 2014 in which more than 3,500 samples worldwide were analyzed, fumonisins were found in 82 per cent of all corn samples with an average contamination of over 2,200ppb.
In 2013, Biomin became the first company to receive the European Commission authorisation for feed additives with mycotoxin-counteracting properties. The authorizations were for the deoxynivalenol-biotransforming product Biomin® BBSH 797 and the aflatoxin-binding bentonite Mycofix® Secure.
FUMzyme, the result of years of intensive research at the Biomin Research Center in Austria, exemplifies the innovation lead of Biomin in developing revolutionary strategies to counteract mycotoxins.
Biomin will be at EuroTier 2014 - Hall 16/B11.
For more on mycotoxin risk management, visit www.Biomin.net/en/species/pigs/mycotoxins/.
|ThePigSite News Desk||Read more Biomin News here|